Results 171 to 180 of about 4,911,045 (202)

Induced pluripotent stem cells — opportunities for disease modelling and drug discovery

Nature Reviews Drug Discovery, 2011
George Q. Daley, Berta Strulovici
exaly  

Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study

Gastroenterology, 2015
Herbert L Bonkovsky, Lawrence Liu, Robert J Fontana   +2 more
exaly  

Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States

Gastroenterology, 2008
Herbert L Bonkovsky, Robert J Fontana, Paul B Watkins   +2 more
exaly  

Drug-induced steatohepatitis

Expert Opinion on Drug Metabolism and Toxicology, 2017
Ajit Dash, Brian R Wamhoff
exaly  

Drug-induced phospholipidosis

FEBS Letters, 2006
Jürgen Borlak
exaly  

Incidence, Presentation, and Outcomes in Patients With Drug-Induced Liver Injury in the General Population of Iceland

Gastroenterology, 2013
Einar S Björnsson, Sigurgeir Olafsson, Helgi K Björnsson   +2 more
exaly  

Incidence and time trends of drug-induced parkinsonism: A 30-year population-based study

Movement Disorders, 2017
Brandon Grossardt, Michelle M Mielke
exaly  

Food and Drug Administration, Partner in Drug Development†

Ca-A Cancer Journal for Clinicians, 2006
J W Yates, Jérôme W Yates
exaly  

Does drug-induced dyskinesia exist?

InPharma, 1975
openaire   +1 more source

Drug-Induced Nephrotoxicity: Pathogenic Mechanisms, Biomarkers and Prevention Strategies

Current Drug Metabolism, 2018
Huizi Wu
exaly